Reappraisal of xenobiotic-induced, oxidative stress-mediated cellular injury in chronic pancreatitis: A systematic review

World Journal of Gastroenterology

Volumn 20, Issue 11, 2014, Pages 3033-3043

  Siriwardena, Ajith K ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cellular injury; Chronic pancreatitis; Cytochrome P450; Oxidative stress; Xenobiotics

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; XENOBIOTIC AGENT; SUPEROXIDE DISMUTASE; TRACE ELEMENT;

ACINAR CELL; APOPTOSIS; CELL DAMAGE; CHRONIC PANCREATITIS; CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; HUMAN; OXIDATIVE STRESS; REVIEW; SYSTEMATIC REVIEW; ANIMAL; CHEMICALLY INDUCED; DEFICIENCY; ENZYME INDUCTION; ENZYMOLOGY; EXPOSURE; LIVER CELL; METABOLISM; PANCREATITIS, CHRONIC;

ACINAR CELLS; ANIMALS; ANTIOXIDANTS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; GLUTATHIONE TRANSFERASE; HEPATOCYTES; HUMANS; INHALATION EXPOSURE; MICRONUTRIENTS; OXIDATIVE STRESS; PANCREATITIS, CHRONIC; SUPEROXIDE DISMUTASE; XENOBIOTICS;

EID: 84896443270     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i11.3033     Document Type: Review

References (69)

1. Braganza JM, Dormandy TL. Micronutrient therapy for chronic pancreatitis: rationale and impact. JOP 2010; 11: 99-112 [PMID: 20208316]
2. Wallig MA. Xenobiotic metabolism, oxidant stress and chronic pancreatitis. Focus on glutathione. Digestion 1998; 59 Suppl 4: 13-24 [PMID: 9832632 DOI: 10.1159/000051439]
3. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009; 30: 42-59 [PMID: 18601945 DOI: 10.1016/j.mam.2008.05.005]
4. Guyan PM, Uden S, Braganza JM. Heightened free radical activity in pancreatitis. Free Radic Biol Med 1990; 8: 347-354 [PMID: 2379863 DOI: 10.1016/0891-5849(90)90100-W]
5. Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther 1990; 4: 357-371 [PMID: 2103755 DOI: 10.1111/j.1365-2036.1990.tb00482.x]
6. Uden S, Schofield D, Miller PF, Day JP, Bottiglier T, Braganza JM. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther 1992; 6: 229-240 [PMID: 1600043 DOI: 10.1111/j.1365-2036.1992.tb00266.x]
7. Segal I. Pancreatitis in Soweto, South Africa. Focus on alcohol-related disease. Digestion 1998; 59 Suppl 4: 25-35 [PMID: 9832633 DOI: 10.1159/000051440]
8. McCloy R. Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion 1998; 59 Suppl 4: 36-48 [PMID: 9832634 DOI: 10.1159/000051441]
9. De las Heras Castaño G, García de la Paz A, Fernández MD, Fernández Forcelledo JL. Use of antioxidants to treat pain in chronic pancreatitis. Rev Esp Enferm Dig 2000; 92: 375-385 [PMID: 10985097]
10. Uomo G, Talamini G, Rabitti PG. Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients. Dig Liver Dis 2001; 33: 58-62 [PMID: 11303976 DOI: 10.1016/S1590-8658(01)80136-5]
11. Kirk GR, White JS, McKie L, Stevenson M, Young I, Clements WD, Rowlands BJ. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg 2006; 10: 499-503 [PMID: 16627214 DOI: 10.1016/j.gassur.2005.08.035]
12. Siriwardena AK, Mason JM, Sheen AJ, Makin AJ, Shah NS. Antioxidant therapy does not reduce pain in patients with chronic pancreatitis: the ANTICIPATE study. Gastroenterology 2012; 143: 655-663. e1 [PMID: 22683257 DOI: 10.1053/j.gastro.2012.05.046]
13. Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bassi C, Malfertheiner P, George SL, Johnson CD. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 2005; 100: 918-926 [PMID: 15784041 DOI: 10.1111/j.1572-0241.2005.40859.x]
14. Braganza JM. Limitations of patient selection and other issues in chronic pancreatitis antioxidant trial. Gastroenterology 2013; 144: e17-e18 [PMID: 23357060 DOI: 10.1053/j.gastro.2012.12.034]
15. Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136: 149-159. e2 [PMID: 18952082 DOI: 10.1053/j.gastro.2008.09.028]
16. EUROPAC. The European Registry of hereditary pancreatitis and familial pancreatic cancer. Available from: URL: http://www.europac-org.eu
17. McNamee R, Braganza JM, Hogg J, Leck I, Rose P, Cherry NM. Occupational exposure to hydrocarbons and chronic pancreatitis: a case-referent study. Occup Environ Med 1994; 51: 631-637 [PMID: 7951796 DOI: 10.1136/oem.51.9.631]
18. Jeppe CY, Smith MD. Transversal descriptive study of xenobiotic exposures in patients with chronic pancreatitis and pancreatic cancer. JOP 2008; 9: 235-239 [PMID: 18326937]
19. Segal I, Ally R, Hunt LP, Sandle LN, Ubbink JB, Braganza JM. Insights into the development of alcoholic chronic pancreatitis at Soweto, South Africa: a controlled cross-sectional study. Pancreas 2011; 40: 508-516 [PMID: 21499204 DOI: 10.1097/MPA.0b013e318214f94a]
20. Foster JR, Idle JR, Hardwick JP, Bars R, Scott P, Braganza JM. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 1993; 169: 457-463 [PMID: 8501544 DOI: 10.1002/path.1711690412]
21. Wacke R, Kirchner A, Prall F, Nizze H, Schmidt W, Fischer U, Nitschke FP, Adam U, Fritz P, Belloc C, Drewelow B. Up-regulation of cytochrome P450 1A2, 2C9, and 2E1 in chronic pancreatitis. Pancreas 1998; 16: 521-528 [PMID: 9598815 DOI: 10.1097/00006676-199805000-00011]
22. Standop J, Schneider M, Ulrich A, Büchler MW, Pour PM. Differences in immunohistochemical expression of xenobiotic-metabolizing enzymes between normal pancreas, chronic pancreatitis and pancreatic cancer. Toxicol Pathol 2003; 31: 506-513 [PMID: 14692619]
23. Pavek P, Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 2008; 9: 129-143 [PMID: 18288955 DOI: 10.2174/138920008783571774]
24. Apte MV, Pirola RC, Wilson JS. Mechanisms of alcoholic pancreatitis. J Gastroenterol Hepatol 2010; 25: 1816-1826 [PMID: 21091991 DOI: 10.1159/000090170]
25. Nelson DR. The cytochrome p450 homepage. Hum Genomics 2009; 4: 59-65 [PMID: 19951895]
26. Zordoky BN, El-Kadi AO. Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 2009; 10: 164-178 [PMID: 19275551 DOI: 10.2174/138920009787522151]
27. Burim RV, Canalle R, de Martinelli AL, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 2004; 19: 291-298 [PMID: 15215328 DOI: 10.1093/mutage/geh034]
28. Wallace K, Marek CJ, Currie RA, Wright MC. Exocrine pancreas trans-differentiation to hepatocytes--a physiological response to elevated glucocorticoid in vivo. J Steroid Biochem Mol Biol 2009; 116: 76-85 [PMID: 19446026 DOI: 10.1016/j.jsbmb.2009.05.002]
29. Ulrich AB, Standop J, Schmied BM, Schneider MB, Lawson TA, Pour PM. Species differences in the distribution of drug-metabolizing enzymes in the pancreas. Toxicol Pathol 2002; 30: 247-253 [PMID: 11950168 DOI: 10.1080/019262302753559588]
30. Bruce JI, Elliott AC. Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signalling in rat pancreatic acinar cells. Br J Pharmacol 2000; 131: 761-771 [PMID: 11030726 DOI: 10.1038/sj.bjp.0703631]
31. Mankad P, James A, Siriwardena AK, Elliott AC, Bruce JI. Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump. J Biol Chem 2012; 287: 1823-1836 [PMID: 22128146 DOI: 10.1074/jbc.M111.326272]
32. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600 [PMID: 8770536 DOI: 10.3109/10409239509083491]
33. Ulrich AB, Schmied BM, Matsuzaki H, Lawson TA, Friess H, Andrén-Sandberg A, Büchler MW, Pour PM. Increased expression of glutathione S-transferase-pi in the islets of patients with primary chronic pancreatitis but not secondary chronic pancreatitis. Pancreas 2001; 22: 388-394 [PMID: 11345140 DOI: 10.1097/00006676-200105000-00009]
34. Milnerowicz H, Jabłonowska M, Bizoń A. Change of zinc, copper, and metallothionein concentrations and the copper-zinc superoxide dismutase activity in patients with pancreatitis. Pancreas 2009; 38: 681-688 [PMID: 19629005 DOI: 10.1097/MPA.0b013e3181a53d1]
35. Hausmann DH, Porstmann T, Weber I, Hausmann S, Dummler W, Liebe S, Emmrich J. Cu/Zn-SOD in human pancreatic tissue and pancreatic juice. Int J Pancreatol 1997; 22: 207-213 [PMID: 9444552]
36. Rahman SH, Nanny C, Ibrahim K, O'Reilly D, Larvin M, Kingsnorth AJ, McMahon MJ. Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity. Dig Dis Sci 2005; 50: 1376-1383 [PMID: 16047490 DOI: 10.1007/s10620-005-2790-7]
37. Abu-Hilal M, McPhail MJ, Marchand L, Johnson CD. Malondialdehyde and superoxide dismutase as potential markers of severity in acute pancreatitis. JOP 2006; 7: 185-192 [PMID: 16525202]
38. Wang X, Vatamaniuk MZ, Roneker CA, Pepper MP, Hu LG, Simmons RA, Lei XG. Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity. Antioxid Redox Signal 2011; 14: 391-401 [PMID: 20586612 DOI: 10.1089/ars.2010.3302]
39. Cuzzocrea S, Genovese T, Mazzon E, Di Paola R, Muià C, Britti D, Salvemini D. Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock 2004; 22: 254-261 [PMID: 15316396 DOI: 10.1097/01.shk.0000132490.79498.11]
40. Sandilands D, Jeffrey IJ, Haboubi NY, MacLennan IA, Braganza JM. Abnormal drug metabolism in chronic pancreatitis. Treatment with antioxidants. Gastroenterology 1990; 98: 766-772 [PMID: 2298375]
41. Aghdassi AA, Mayerle J, Christochowitz S, Weiss FU, Sendler M, Lerch MM. Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair 2011; 4: 26 [PMID: 22133269]
42. Westlund KN, Vera-Portocarrero L. Rat models of pancreatitis pain. Methods Mol Biol 2012; 851: 223-238 [PMID: 22351095 DOI: 10.1007/978-1-61779-561-9_17]
43. Gómez JA, Molero X, Vaquero E, Alonso A, Salas A, Malagelada JR. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004; 287: G162-G169 [PMID: 15001429 DOI: 10.1152/ajpgi.00333.2003]
44. Yoo BM, Oh TY, Kim YB, Yeo M, Lee JS, Surh YJ, Ahn BO, Kim WH, Sohn S, Kim JH, Hahm KB. Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 2005; 5: 165-176 [PMID: 15849487 DOI: 10.1159/000085268]
45. de Las Heras-Castaño G, García-Unzueta MT, Domínguez-Diez A, Fernández-González MD, García-de la Paz AM, Mayorga-Fernández M, Fernández-Fernández F. Pancreatic fibrosis in rats and its response to antioxidant treatment. JOP 2005; 6: 316-324 [PMID: 16006681]
46. Mas MR, Isik AT, Yamanel L, Inal V, Tasci I, Deveci S, Mas N, Comert B, Akay C. Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model. Pancreas 2006; 33: 77-81 [PMID: 16804416 DOI: 10.1097/01.mpa.0000222316.74607.07]
47. Lu XL, Song YH, Fu YB, Si JM, Qian KD. Ascorbic acid alleviates pancreatic damage induced by dibutyltin dichloride (DBTC) in rats. Yonsei Med J 2007; 48: 1028-1034 [PMID: 18159597 DOI: 10.3349/ymj.2007.48.6.1028]
48. Wei L, Yamamoto M, Harada M, Otsuki M. Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. Lab Invest 2011; 91: 872-884 [PMID: 21383674 DOI: 10.1038/labinvest.2011.41]
49. Li XC, Lu XL, Chen HH. α-Tocopherol treatment ameliorates chronic pancreatitis in an experimental rat model induced by trinitrobenzene sulfonic acid. Pancreatology 2011; 11: 5-11 [PMID: 21311207 DOI: 10.1159/000309252]
50. Jiang F, Liao Z, Hu LH, Du YQ, Man XH, Gu JJ, Gao J, Gong YF, Li ZS. Comparison of antioxidative and antifibrotic effects of α-tocopherol with those of tocotrienol-rich fraction in a rat model of chronic pancreatitis. Pancreas 2011; 40: 1091-1096 [PMID: 21926544 DOI: 10.1097/MPA.0b013e31821b59c6]
51. Matsushita K, Mizushima T, Shirahige A, Tanioka H, Sawa K, Ochi K, Tanimoto M, Koide N. Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis. Acta Med Okayama 2012; 66: 329-334 [PMID: 22918205]
52. Forsmark CE, Liddle RA. The challenging task of treating painful chronic pancreatitis. Gastroenterology 2012; 143: 533-535 [PMID: 22841737 DOI: 10.1053/j.gastro.2012.07.029]
53. Mason J, Siriwardena AK. Designing future clinical trials in acute pancreatitis. Pancreatology 2005; 5: 113-115 [PMID: 15849481 DOI: 10.1159/000085261]
54. National Information Center on Health Services Research and Health Care Technology (NICHSR). HTA 101: V. APPRAISING THE EVIDENCE. Accessed 7th May 2013. Available from: URL: http://www.nlm.nih.gov/nichsr/hta101/ta10107.html
55. Braganza JM, Jolley JE, Lee WR. Occupational chemicals and pancreatitis: a link? Int J Pancreatol 1986; 1: 9-19 [PMID: 3320224]
56. González AM, Garcia T, Samper E, Rickmann M, Vaquero EC, Molero X. Assessment of the protective effects of oral tocotrienols in arginine chronic-like pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011; 301: G846-G855 [PMID: 21852363 DOI: 10.1152/ajpgi.00485.2010]
57. Hackert T, Werner J. Antioxidant therapy in acute pancreatitis: experimental and clinical evidence. Antioxid Redox Signal 2011; 15: 2767-2777 [PMID: 21834688 DOI: 10.1089/ars.2011.4076]
58. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261 [PMID: 23622135 DOI: 10.1053/j.gastro.2013.01.068]
59. Hirota M, Shimosegawa T, Masamune A, Kikuta K, Kume K, Hamada S, Kihara Y, Satoh A, Kimura K, Tsuji I, Kuriyama S. The sixth nationwide epidemiological survey of chronic pancreatitis in Japan. Pancreatology 2012; 12: 79-84 [PMID: 22487515 DOI: 10.1016/j.pan.2012.02.005]
60. Lankisch PG, Assmus C, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german population. Pancreatology 2002; 2: 469-477 [PMID: 12378115 DOI: 10.1159/000064713]
61. Johnson CD, Hosking S. National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960-88. Gut 1991; 32: 1401-1405 [PMID: 1752477 DOI: 10.1136/gut.32.11.1401]
62. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145 [PMID: 8841182 DOI: 10.1038/ng1096-141]
63. LaRusch J, Whitcomb DC. Genetics of pancreatitis. Curr Opin Gastroenterol 2011; 27: 467-474 [PMID: 21844754 DOI: 10.1097/MOG.0b013e328349e2f8]
64. Whitcomb DC. Genetic aspects of pancreatitis. Annu Rev Med 2010; 61: 413-424 [PMID: 20059346 DOI: 10.1146/annurev.med.041608.121416]
65. Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Alkaade S, Amann ST, Anderson MA, Baillie J, Banks PA, Conwell D, Coté GA, Cotton PB, DiSario J, Farrer LA, Forsmark CE, Johnstone M, Gardner TB, Gelrud A, Greenhalf W, Haines JL, Hartman DJ, Hawes RA, Lawrence C, Lewis M, Mayerle J, Mayeux R, Melhem NM, Money ME, Muniraj T, Papachristou GI, Pericak-Vance MA, Romagnuolo J, Schellenberg GD, Sherman S, Simon P, Singh VP, Slivka A, Stolz D, Sutton R, Weiss FU, Wilcox CM, Zarnescu NO, Wisniewski SR, O'Connell MR, Kienholz ML, Roeder K, Barmada MM, Yadav D, Devlin B. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012; 44: 1349-1354 [PMID: 23143602 DOI: 10.1038/ng.2466]
66. Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, Esposito I, Friess H, Gress TM, Habisch HJ, Hwang RF, Jaster R, Kleeff J, Klöppel G, Kordes C, Logsdon CD, Masamune A, Michalski CW, Oh J, Phillips PA, Pinzani M, Reiser-Erkan C, Tsukamoto H, Wilson J. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012; 61: 172-178 [PMID: 22115911]
67. Ceyhan GO, Demir IE, Rauch U, Bergmann F, Müller MW, Büchler MW, Friess H, Schäfer KH. Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. Am J Gastroenterol 2009; 104: 2555-2565 [PMID: 19568227 DOI: 10.1038/ajg.2009.380]
68. Bouwense SA, Olesen SS, Drewes AM, Frøkjær JB, van Goor H, Wilder-Smith OH. Is altered central pain processing related to disease stage in chronic pancreatitis patients with pain? An exploratory study. PLoS One 2013; 8: e55460 [PMID: 23405154 DOI: 10.1371/journal.pone.0055460]
69. Burton F, Alkaade S, Collins D, Muddana V, Slivka A, Brand RE, Gelrud A, Banks PA, Sherman S, Anderson MA, Romagnuolo J, Lawrence C, Baillie J, Gardner TB, Lewis MD, Amann ST, Lieb JG, O'Connell M, Kennard ED, Yadav D, Whitcomb DC, Forsmark CE. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther 2011; 33: 149-159 [PMID: 21083584 DOI: 10.1111/j.1365-2036.2010.04491.x]